Eating Almonds Before a Meal to Control Blood Sugar

Recruiting now · Not applicable

Conditions studied: Glucose Control, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Precision Medicine, Nutrition

In brief

The goal of this study is to learn whether eating a small serving of almonds before meals can improve blood sugar control in adults who have early signs of problems with blood sugar regulation. The main questions it aims to answer are: 1. Does eating almonds before a meal reduce the rise in blood sugar after eating? 2. Do some people consistently benefit more than others from eating almonds before meals?

Key facts

Study ID

NCT07603739

Run by

Pennington Biomedical Research Center

People needed

25

Starts

2026-06-23

Expected to finish

2028-07-01

Last updated by the study team

2026-07-17

Who can join

Age: 25 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 25-50 years
• Females over 40 years must have had a cycle in the last 6 months
• Body mass index (BMI) at least 18.5 and at most 55.0 kg/m2
• Impaired blood glucose by at least one of the following criteria:
• Fasting blood glucose at least 100 mg/dL (5.6 mmol/L) and less than 125 mg/dL (6.9 mmol/L)
• HbA1c at least 5.7% and less than 6.5%
• Willing and able to comply with study foods
• Willing and able to ingest acetaminophen as part of study procedures
• Able to read, speak, and understand English

You may not qualify if…

• Weight change ≥5% in past 6 months, actively trying to lose weight, or unwilling to remain weight stable throughout the study based on self-report
• Recent history within past 12 months of medical provider-diagnosed cardiovascular, renal, or liver disease that required treatment
• Current or past diagnosis of cancer (except skin cancer) in the last 5 years
• Current or past diagnosis of type 1 or type 2 diabetes
• Recent history within past 12 months of medical provider-diagnosed gastrointestinal or neurological disorders if not managed/stable for at least 3 months (with or without treatment)
• Recent history within past 12 months of medical provider-diagnosed psychiatric disorders including eating disorders or severe depression if not managed/stable for at least 3 months (with or without treatment)
• Food allergies or other reasons preventing consumption of study foods
• Any glucose-lowering medication except biguanides (e.g., Metformin) if stable for at least 3 months or incretins (i.e., GLP-1RA-based) if stable for at least 3 months
• Current smoking or vaping or history of smoking or vaping in the past 6 months
• Binge and/or heavy drinking (i.e., >3 drinks on any given occasion and/or >7 drinks/week)
• Currently pregnant or planning to become pregnant or breastfeed in the next 3 months by self-report

Where it is running

• Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.